Skip to main content
logo
Marksans Pharma Limited (NSE:MARKSANS)
India flag India · Delayed Price · Currency is INR
183.44
-0.26 (-0.14%)
Oct 30, 2025, 3:30 PM IST

Marksans Pharma Revenue

Marksans Pharma had revenue of 6.20B INR in the quarter ending June 30, 2025, with 4.97% growth. This brings the company's revenue in the last twelve months to 26.52B, up 16.94% year-over-year. In the fiscal year ending March 31, 2025, Marksans Pharma had annual revenue of 26.23B with 20.46% growth.

Revenue (ttm)
26.52B
Revenue Growth
+16.94%
P/S Ratio
3.13
Revenue / Employee
14.41M
Employees
1,840
Market Cap
83.13B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 202526.23B4.45B20.46%
Mar 31, 202421.77B3.25B17.56%
Mar 31, 202318.52B3.61B24.23%
Mar 31, 202214.91B1.15B8.33%
Mar 31, 202113.76B2.42B21.32%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Sun Pharmaceutical Industries537.77B
Aurobindo Pharma320.25B
Cipla274.80B
Zydus Lifesciences236.08B
Apollo Hospitals Enterprise225.51B
Glenmark Pharmaceuticals134.56B
Alkem Laboratories133.04B
Mankind Pharma129.10B
Revenue Rankings

Marksans Pharma News

More News